Julian Guillaumin, DVM, DACVECC, DECVECC joins us in this episode to discuss his JFMS Clinical Spotlight article, “Feline Aortic Thromboembolism: Recent advances and future prospects.” Dr. Guillaumin shares what sparked his interest in researching feline aortic thromboembolism (FATE), and details how the research and treatment options have changed over the past decade. Additionally, the discussion notes new treatment approaches for general practitioners in managing FATE in patients, why aspirin is no longer recommended, and what therapeutics to use instead. Other topics that are explored include the challenges in managing long-term pain in survival patients, the research finding that surprised Dr. Guillaumin, and the advances he hopes to see in protocols developed to mitigate repercussion injuries of FATE patients.
Read the article and access the supplemental material referenced in the episode:
In this episode, Dr. Jonathan Stockman, DVM, DACVIM (Nutrition), discusses his recent JFMS article, “Dietary phosphorus and renal disease in cats: where are we?”...
Our latest episode of "All Cats Considered" features Frane Banovic, DVM, PhD, DECVD, a veterinary dermatologist from the University of Georgia, discussing feline immune-mediated...
In this episode of "All Cats Considered," Michelle Meyer, DVM, a general practitioner and past president of the FelineVMA, joins Luca Ferasin, DVM, PhD,...